Concepedia

Nathalie Letarte

NL

Statistics

Publications

8

Citations

505

H-Index

8

Active since

2011

Affiliations

Université de Montréal(Current)

Centre Hospitalier de l’Université de Montréal

Centre Hospitalier Universitaire Sainte-Justine

Hôpital Maisonneuve-Rosemont

Montreal Heart Institute

Nathalie Letarte is an author at Université de Montréal specializing in medicine, oncology, and pharmacology.

Publications per year

2011–2020

8

Publications

8

Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors

Arielle Elkrief, Layal El Raichani, Corentin Richard et al. · OncoImmunology · 2019 · 207 citations · Full text

Medicine, Oncology, Pharmacology +17

An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics

Simon de Denus, Nathalie Letarte, Thierry Hurlimann et al. · Pharmacogenomics · 2013 · 80 citations

Medicine, Pharmacotherapy, Pharmacy Practice +10

Managing Treatment–Related Adverse Events Associated with Alk Inhibitors

J. Rothenstein, Nathalie Letarte · Current Oncology · 2014 · 68 citations · Full text

Medicine, Oncology, Pharmacology +16

Hematologic adverse events associated with temozolomide

John L. Villano, Nathalie Letarte, Janny ManYan Yu et al. · Cancer Chemotherapy and Pharmacology · 2011 · 60 citations

Medicine, Hematology, Chemotherapy +10

A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada

C. Beauchemin, Nathalie Letarte, K. Mathurin et al. · Journal of Medical Economics · 2016 · 34 citations

Pharmacy, Oncology, Pharmacoeconomics +17

1–5 of 8